Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 1.2B | 1.7B | 874M | 1.2B |
| Cost of revenue | 1.0B | 1.6B | 1.3B | 1.6B |
| Gross profit | 206M | 170M | -392M | -451M |
| Operating expense | ||||
| Research & development | 381M | 374M | 350M | 428M |
| Selling general and admin | 480M | 457M | 427M | 496M |
| Other operating expenses | — | — | — | — |
| Operating income | -655M | -661M | -1.2B | -1.4B |
| Non operating interest income | ||||
| Income | 81M | 83M | 95M | 95M |
| Expense | 72M | 81M | 87M | 75M |
| Other income expense | 107M | -81M | 61M | -101M |
| Pretax income | -539M | -740M | -1.1B | -1.5B |
| Tax provision | 2M | 3M | 0 | 1M |
| Net income | -541M | -743M | -1.1B | -1.5B |
| Basic EPS | -0.5 | -0.7 | -1.1 | -1.5 |
| Diluted EPS | -0.5 | -0.7 | -1.1 | -1.5 |
| Basic average shares | 1.1B | 1.1B | 1.0B | 1.0B |
| Diluted average shares | 1.1B | 1.1B | 1.0B | 1.0B |
| EBITDA | -267M | -441M | -754M | -1.1B |
| Net income from continuing op. | -541M | -743M | -1.1B | -1.5B |
| Minority interests | -4M | — | — | — |
| Preferred stock dividends | — | — | — | — |